Results 61 to 70 of about 14,359 (261)
ABSTRACT Background Hypoattenuated leaflet thickening (HALT) after transcatheter aortic valve implantation (TAVI) detected on multidetector computed tomography (MDCT) is considered leaflet thrombosis. However, its impact on long‐term clinical outcomes remains unclear. This study aimed to investigate the impact of early HALT detection after TAVI on long‐
Juri Iwata+15 more
wiley +1 more source
Hemodynamic and physical performance during maximal exercise in patients with an aortic bioprosthetic valve Comparison of stentless versus stented bioprostheses [PDF]
OBJECTIVESThe objective of this study was to compare stentless bioprostheses with stented bioprostheses with regard to their hemodynamic behavior during exercise.BACKGROUNDStentless aortic bioprostheses have better hemodynamic performances at rest than ...
Cartier, Paul+5 more
core +1 more source
ABSTRACT Background and Aims Percutaneous pulmonary valve implantation was introduced two decades ago as a low‐risk alternative for patients previously operated with conduits presenting RVOT dysfunction. Recently, Sapien valve was approved for use in the pulmonary position but this valve cannot be used for RVOT larger than 29 mm.
João Luiz Langer Manica+13 more
wiley +1 more source
Clinical outcome and hemodynamic behavior of the Labcor Dokimos Plus aortic valve [PDF]
Die Labcor Dokimos Plus Bioprothese zeigte intraoperativ keine Komplikationen und postoperativ zufriedenstellende klinische Ergebnisse mit niedriger Morbidität und Mortalität.
Zhigalov, Konstantin
core +1 more source
Transcatheter Aortic Valve Replacement in Special Populations
Since its food and drug administration (FDA) approval in 2011, transcatheter aortic valve replacement (TAVR) has revolutionized the highly prevalent disease of aortic stenosis.
Khansa Ahmad+7 more
doaj +1 more source
Bridging aortic valve surgery to 21st century. what can a surgeon do [PDF]
Aortic valve stenosis is the most clinically relevant valvular heart disease in the elderlies. Surgical aortic valve replacement (SAVR) represented, for decades, the standard of care for the treatment of severe aortic stenosis.
Barretta, Antonio+13 more
core +1 more source
The Beneficial Effect of Anticoagulation in Aortic Bioprosthesis is Associated with its Size
Objective: To evaluate the clinical and echocardiographic outcomes in aortic valve replacement (AVR) patients with aortic bioprosthesis under oral anticoagulation (OA). Methods: Patients who underwent AVR with bioprosthesiswere prospectively enrolled.
Victor Dayan+5 more
doaj +1 more source
Very little is known about the occurrence of bioprosthetic tricuspid valve stenosis in the Indian population that usually occurs within 8–10 years following tricuspid valve replacement (TVR) with a bioprosthetic valve.
Ganeshrao Patilba Sapkal+1 more
doaj +1 more source
Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis [PDF]
Objective: The ATS 3f Enable® Bioprosthesis is a self-expanding valve with a tubular design that allows for decreased leaflet stress and preservation of aortic sinuses. We report the midterm results of a prospective, multicenter clinical study evaluating
Bartus, Krzysztof+7 more
core
Comparison of the Hemodynamic Performance of Percutaneous and Surgical Bioprostheses for the Treatment of Severe Aortic Stenosis [PDF]
ObjectivesThis study was undertaken to compare the hemodynamic performance of a percutaneous bioprosthesis to that of surgically implanted (stented and stentless) bioprostheses for the treatment of severe aortic stenosis.MethodsFifty patients who ...
Altwegg, Lukas+11 more
core +1 more source